Ocuphire Pharma, Inc. (OCUP)
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.
$38.12M
Ms. Mina Patel Sooch M.B.A., MBA
8.00
Farmington Hills, MI
Nov 10, 2005
-2.69
$-0.54
9.86
10.68
-85.75%
-2.40
-0.20
0.83
2.09
10.68
-31.46%
-30.19%
Similar stocks (13)
EyePoint Pharmaceuticals, Inc.
EYPT
Rigel Pharmaceuticals, Inc.
RIGL
Kodiak Sciences Inc.
KOD
Checkpoint Therapeutics, Inc.
CKPT
Protalix BioTherapeutics, Inc.
PLX
SELLAS Life Sciences Group, Inc.
SLS
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Fortress Biotech, Inc.
FBIOP
Fortress Biotech, Inc.
FBIO
Eyenovia, Inc.
EYEN
Cognition Therapeutics, Inc.
CGTX
Mustang Bio, Inc.
MBIO
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (8)
iShares Micro-Cap ETF
IWC
0.00828%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (13)
EyePoint Pharmaceuticals, Inc.
EYPT
Rigel Pharmaceuticals, Inc.
RIGL
Kodiak Sciences Inc.
KOD
Checkpoint Therapeutics, Inc.
CKPT
Protalix BioTherapeutics, Inc.
PLX
SELLAS Life Sciences Group, Inc.
SLS
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Fortress Biotech, Inc.
FBIOP
Fortress Biotech, Inc.
FBIO
Eyenovia, Inc.
EYEN
Cognition Therapeutics, Inc.
CGTX
Mustang Bio, Inc.
MBIO
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (8)
iShares Micro-Cap ETF
IWC
0.00828%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%